(Q84907800)
Statements
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis (English)
E J Fox
H C Sullivan
S K Gazda
L Mayer
L O'Donnell
K Melia
7 September 2011
scientific article published on 07 September 2011